Objective: To evaluate the effect of a phospholipid-coated microbubble contrast agent for myocardium opacification in comparison with a albumin-coated microbubble contrast agent (Quanfuxian).
Methods: In 10 dogs with single coronary artery stenosis involving the anterior descending branch or circumflex branch randomly received infusion of the two contrast agents through the femoral vein. The myocardial blood flow, heart rate and blood pressure were analyzed qualitatively and quantitatively. The concentration and the particle diameter of the two contrast agents were determined.
Results: The concentration of the phospholipid-coated microbubbles was (1.06-/+0.22) x10(9)/ml, with a diameter of 3.04-/+0.34 microm, similar to the concentration and diameter of Quanfuxian ((1.31-/+0.33)x10(9)/ml and 2.88-/+0.58 microm, respectively, P>0.05). Both of the agents achieved grade three myocardium opacification, and produced no obvious effect on the heart rate and blood pressure. Quantitative analysis of myocardial opacification in terms of myocardial blood volume (A), blood velocity (beta), and blood flow (A x beta) revealed no significant difference between the two agents (P>0.05), and the parameters derived from the two agents showed good correlations (P<0.05, rA=0.809, r beta=0.932, rA.beta=0.925).
Conclusion: The phospholipid-coated microbubble contrast agent shows good effect for myocardial opacification without significant difference from Quanfuxian. Both of the agents are good ultrasound contrast agents for quantitative analysis of myocardium blood flow.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Intercoronary communication: a rare coronary anomaly.
Egypt Heart J
October 2024
All India Institute of Medical Sciences, Nagpur, India.
Article Synopsis
- Intercoronary communication (ICC) is a rare coronary artery anomaly that occurs in only 0.002% of patients undergoing angiography, highlighting the need for clinical awareness.
- A case study details a 56-year-old woman who experienced chest pain and was diagnosed with acute coronary syndrome; angiography revealed a significant stenosis and the existence of ICC, which connected two coronary arteries.
- The study concludes that it's important to differentiate ICC from collaterals, as they have distinct anatomical characteristics and flow patterns, with collaterals usually forming due to obstructive disease.
Ultrasound enhancing agents in cardiovascular imaging: expanding horizons beyond coronary arteries.
Cardiovasc Ultrasound
August 2024
Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
From its inception as a two-dimensional snapshot of the beating heart, echocardiography has become an indelible part of cardiovascular diagnostics. The integration of ultrasound enhancing agents (UEAs) marks a pivotal transition, enhancing its diagnostic acumen beyond myocardial perfusion. These agents have refined echocardiography's capacity to visualize complex cardiac anatomy and pathology with unprecedented clarity, especially in non-coronary artery disease contexts.
View Article and Find Full Text PDFComparison of the Effect of Non-HDL-C/HDL-C Ratio on Coronary Slow Flow with Other Non-Traditional Lipid Markers.
Acta Cardiol Sin
July 2024
Department of Cardiology, Faculty of Medicine, Harran University, Sanliurfa.
Background: Coronary slow flow (CSF) is a microvascular disease characterized by delayed opacification of the epicardial coronary arteries during angiography. The main pathogenesis of CSF is endothelial dysfunction caused by diffuse atherosclerosis. Dyslipidemia is one of the primary factors raising the risk of atherosclerosis.
View Article and Find Full Text PDFApplication of Routine Echocardiography Combined with Contrast-Enhanced Echocardiography in the Diagnosis of Endomyocardial Fibrosis.
Discov Med
December 2023
Ultrasonic Department, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, 510405 Guangzhou, Guangdong, China.
Background: In China, endomyocardial fibrosis (EMF) is a type of restrictive cardiomyopathy that is rare and easy to be misdiagnosed. Our aim was to examine the value of routine echocardiography (RE) combined with contrast-enhanced echocardiography (CEE) in EMF diagnosis.
Methods: We studied 16 EMF patients retrospectively, from 2012 to 2022.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!